{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:58:25Z","timestamp":1790935105592,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008796","name":"Allen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008796","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for the treatment of depressive disorders. Recent clinical reports and studies in animal models have suggested that fluoxetine increases the risk of cardiovascular diseases, but the underlying mechanisms remain unknown. Here, we uncover that fluoxetine disrupts lipid and cholesterol metabolism in primary human endothelial cells (ECs). Fluoxetine triggered an upregulation of cholesterol metabolism genes, leading to the accumulation of lipid droplets in ECs. We find higher levels of cholesterol esters, ceramides, sphingolipids and fatty acids in ECs treated with fluoxetine. The disruption of lipid homeostasis was driven by increased cholesterol biosynthesis, as well as low-density lipoprotein (LDL) uptake and transcytosis via the LDL receptor. Fluoxetine accumulated in ECs in the endoplasmic reticulum (ER), caused ER expansion and reduced protein translation, without inducing ER stress markers. Mechanistically, fluoxetine activated the SREBP2 transcription factor in an INSIG-dependent manner. SREBP2 inhibition attenuated the fluoxetine-mediated upregulation of the LDL receptor and lipid accumulation. Our findings reveal that fluoxetine reprograms lipid metabolism and leads to endothelial dysfunction.<\/jats:p>","DOI":"10.1038\/s41398-026-04197-x","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:34:14Z","timestamp":1782239654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fluoxetine disrupts cholesterol metabolism in endothelial cells via SREBP2 activation"],"prefix":"10.1038","volume":"16","author":[{"given":"Fabiana","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Geier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tino","family":"R\u00f6xe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiqa","family":"Zulfqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Pr\u00f6nnecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hryhoriy","family":"Stryhanyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3258-3397","authenticated-orcid":false,"given":"Anne","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Kyselova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Karantanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Asad","family":"Farhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Rafael","family":"Rodr\u00edguez-Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saira","family":"Ambreen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Arif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo N. G.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Kl\u00f6ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0208-2065","authenticated-orcid":false,"given":"Matthias","family":"Bl\u00fcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurrum","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes-Niels","family":"Boeckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5497-2855","authenticated-orcid":false,"given":"Carolina E.","family":"Hagberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Chakaroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-6628","authenticated-orcid":false,"given":"Sofia-Iris","family":"Bibli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1970-6236","authenticated-orcid":false,"given":"Bilal N.","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"4197_CR1","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","volume":"386","author":"Global Burden of Disease Study 2013 Collaborators.","year":"2015","unstructured":"Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743\u2013800.","journal-title":"Lancet"},{"key":"4197_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"GBD 2019 Mental Disorders Collaborators.","year":"2022","unstructured":"GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137\u201350.","journal-title":"Lancet Psychiatry"},{"key":"4197_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.65","volume":"2","author":"C Otte","year":"2016","unstructured":"Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, et al. Major depressive disorder. Nat Rev Dis Primer. 2016;2:1\u201320.","journal-title":"Nat Rev Dis Primer"},{"key":"4197_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/0269881115581093","volume":"29","author":"A Cleare","year":"2015","unstructured":"Cleare A, Pariante C, Young A, Anderson I, Christmas D, Cowen P, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol (Oxf). 2015;29:459\u2013525.","journal-title":"J Psychopharmacol (Oxf)"},{"key":"4197_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0163-7258(99)00048-0","volume":"85","author":"C Hiemke","year":"2000","unstructured":"Hiemke C, H\u00e4rtter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther. 2000;85:11\u201328.","journal-title":"Pharmacol Ther"},{"key":"4197_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1021\/cn400186j","volume":"5","author":"CJ Wenthur","year":"2014","unstructured":"Wenthur CJ, Bennett MR, Lindsley CW. Classics in chemical neuroscience: fluoxetine (prozac). ACS Chem Neurosci. 2014;5:14\u201323.","journal-title":"ACS Chem Neurosci"},{"key":"4197_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/hrt.2004.037457","volume":"91","author":"LJ Tata","year":"2005","unstructured":"Tata LJ, West J, Smith C, Farrington P, Card T, Smeeth L, et al. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart. 2005;91:465\u201371.","journal-title":"Heart"},{"key":"4197_CR8","doi-asserted-by":"publisher","first-page":"d4551","DOI":"10.1136\/bmj.d4551","volume":"343","author":"C Coupland","year":"2011","unstructured":"Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343:d4551.","journal-title":"BMJ"},{"key":"4197_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/ATVBAHA.117.310536","volume":"38","author":"M Rami","year":"2018","unstructured":"Rami M, Guillamat-Prats R, Rinne P, Salvermoser M, Ring L, Bianchini M, et al. Chronic intake of the selective serotonin reuptake inhibitor fluoxetine enhances atherosclerosis. Arterioscler Thromb Vasc Biol. 2018;38:1007\u201319.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4197_CR10","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868\u201374.","journal-title":"Nature"},{"key":"4197_CR11","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","volume":"116","author":"MH Criqui","year":"2015","unstructured":"Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116:1509\u201326.","journal-title":"Circ Res"},{"key":"4197_CR12","first-page":"e9349","volume":"12","author":"MA Khan","year":"2020","unstructured":"Khan MA, Hashim MJ, Mustafa H, Baniyas MY, Al Suwaidi SKBM, AlKatheeri R, et al. Global epidemiology of ischemic heart disease: results from the global burden of disease study. Cureus. 2020;12:e9349.","journal-title":"Cureus"},{"key":"4197_CR13","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","volume":"118","author":"MA Gimbrone","year":"2016","unstructured":"Gimbrone MA, Garc\u00eda-Carde\u00f1a G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. 2016;118:620\u201336.","journal-title":"Circ Res"},{"key":"4197_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","volume":"21","author":"J Luo","year":"2020","unstructured":"Luo J, Yang H, Song B-L. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020;21:225\u201345.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4197_CR15","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/sj.npp.1300749","volume":"30","author":"ME Henry","year":"2005","unstructured":"Henry ME, Schmidt ME, Hennen J, Villafuerte RA, Butman ML, Tran P, et al. A Comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: a 19-F MRS study. Neuropsychopharmacology. 2005;30:1576\u201383.","journal-title":"Neuropsychopharmacology"},{"key":"4197_CR16","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1002\/imt2.107","volume":"2","author":"S Chen","year":"2023","unstructured":"Chen S. Ultrafast one-pass FASTQ data preprocessing, quality control, and deduplication using fastp. iMeta. 2023;2:e107.","journal-title":"iMeta"},{"key":"4197_CR17","unstructured":"Babraham Bioinformatics - FastQC A Quality Control tool for High Throughput Sequence Data. https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/ (accessed 2 Oct2023)."},{"key":"4197_CR18","doi-asserted-by":"publisher","first-page":"D942","DOI":"10.1093\/nar\/gkac1071","volume":"51","author":"A Frankish","year":"2023","unstructured":"Frankish A, Carbonell-Sala S, Diekhans M, Jungreis I, Loveland JE, Mudge JM, et al. GENCODE: reference annotation for the human and mouse genomes in 2023. Nucleic Acids Res. 2023;51:D942\u20139.","journal-title":"Nucleic Acids Res"},{"key":"4197_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"4197_CR20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923\u201330.","journal-title":"Bioinformatics"},{"key":"4197_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"4197_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3389\/fphar.2019.00445","volume":"10","author":"R Huang","year":"2019","unstructured":"Huang R, Grishagin I, Wang Y, Zhao T, Greene J, Obenauer JC, et al. The NCATS bioplanet \u2013 an integrated platform for exploring the universe of cellular signaling pathways for toxicology, systems biology, and chemical genomics. Front Pharmacol. 2019;10:445. https:\/\/doi.org\/10.3389\/fphar.2019.00445.","journal-title":"Front Pharmacol"},{"key":"4197_CR23","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkx1013","volume":"46","author":"H Han","year":"2018","unstructured":"Han H, Cho J-W, Lee S, Yun A, Kim H, Bae D, et al. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 2018;46:D380\u20136.","journal-title":"Nucleic Acids Res"},{"key":"4197_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13007-016-0146-2","volume":"12","author":"MA Salem","year":"2016","unstructured":"Salem MA, J\u00fcppner J, Bajdzienko K, Giavalisco P. Protocol: a fast, comprehensive and reproducible one-step extraction method for the rapid preparation of polar and semi-polar metabolites, lipids, proteins, starch and cell wall polymers from a single sample. Plant Methods. 2016;12:45.","journal-title":"Plant Methods"},{"key":"4197_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-10-428","volume":"10","author":"\u00c1 Cuadros-Inostroza","year":"2009","unstructured":"Cuadros-Inostroza \u00c1, Caldana C, Redestig H, Kusano M, Lisec J, Pe\u00f1a-Cort\u00e9s H, et al. TargetSearch - a Bioconductor package for the efficient preprocessing of GC-MS metabolite profiling data. BMC Bioinformatics. 2009;10:428.","journal-title":"BMC Bioinformatics"},{"key":"4197_CR26","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/j.1462-2920.2011.02681.x","volume":"14","author":"L Polerecky","year":"2012","unstructured":"Polerecky L, Adam B, Milucka J, Musat N, Vagner T, Kuypers MMM. Look@NanoSIMS-a tool for the analysis of nanoSIMS data in environmental microbiology. Environ Microbiol. 2012;14:1009\u201323.","journal-title":"Environ Microbiol"},{"key":"4197_CR27","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cell.2017.12.006","volume":"172","author":"I Piazza","year":"2018","unstructured":"Piazza I, Kochanowski K, Cappelletti V, Fuhrer T, Noor E, Sauer U, et al. A map of protein-metabolite interactions reveals principles of chemical communication. Cell. 2018;172:358\u201372.e23.","journal-title":"Cell"},{"key":"4197_CR28","doi-asserted-by":"publisher","first-page":"e2995","DOI":"10.21769\/BioProtoc.2995","volume":"8","author":"F Tetzlaff","year":"2018","unstructured":"Tetzlaff F, Fischer A. Human endothelial cell spheroid-based sprouting angiogenesis assay in collagen. Bio-Protoc. 2018;8:e2995.","journal-title":"Bio-Protoc"},{"key":"4197_CR29","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1111\/bph.12616","volume":"171","author":"F Bian","year":"2014","unstructured":"Bian F, Yang X, Zhou F, Wu P-H, Xing S, Xu G, et al. C-reactive protein promotes atherosclerosis by increasing LDL transcytosis across endothelial cells. Br J Pharmacol. 2014;171:2671\u201384.","journal-title":"Br J Pharmacol"},{"key":"4197_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.tcb.2019.12.007","volume":"30","author":"J Decelle","year":"2020","unstructured":"Decelle J, Veronesi G, Gallet B, Stryhanyuk H, Benettoni P, Schmidt M, et al. Subcellular chemical imaging: new avenues in cell biology. Trends Cell Biol. 2020;30:173\u201388.","journal-title":"Trends Cell Biol"},{"key":"4197_CR31","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1039\/C9JA00171A","volume":"34","author":"F Gyngard","year":"2019","unstructured":"Gyngard F, Steinhauser ML. Biological explorations with nanoscale secondary ion mass spectrometry. J Anal At Spectrom. 2019;34:1534\u201345.","journal-title":"J Anal At Spectrom"},{"key":"4197_CR32","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nrd1821","volume":"4","author":"DT Wong","year":"2005","unstructured":"Wong DT, Perry KW, Bymaster FP. The discovery of fluoxetine hydrochloride (Prozac). Nat Rev Drug Discov. 2005;4:764\u201374.","journal-title":"Nat Rev Drug Discov"},{"key":"4197_CR33","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","volume":"184","author":"PC Casarotto","year":"2021","unstructured":"Casarotto PC, Girych M, Fred SM, Kovaleva V, Moliner R, Enkavi G, et al. Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell. 2021;184:1299\u20131313.e19.","journal-title":"Cell"},{"key":"4197_CR34","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.cell.2020.01.015","volume":"180","author":"J Kalucka","year":"2020","unstructured":"Kalucka J, de Rooij LPMH, Goveia J, Rohlenova K, Dumas SJ, Meta E, et al. Single-cell transcriptome atlas of murine endothelial cells. Cell. 2020;180:764\u201379.e20.","journal-title":"Cell"},{"key":"4197_CR35","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s44161-024-00436-w","volume":"3","author":"JT Brash","year":"2024","unstructured":"Brash JT, Diez-Pinel G, Colletto C, Castellan RFP, Fantin A, Ruhrberg C. The BulkECexplorer compiles endothelial bulk transcriptomes to predict functional versus leaky transcription. Nat Cardiovasc Res. 2024;3:460\u201373.","journal-title":"Nat Cardiovasc Res"},{"key":"4197_CR36","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1194\/jlr.R067595","volume":"57","author":"J Han","year":"2016","unstructured":"Han J, Kaufman RJ. The role of ER stress in lipid metabolism and lipotoxicity. J Lipid Res. 2016;57:1329\u201338.","journal-title":"J Lipid Res"},{"key":"4197_CR37","doi-asserted-by":"publisher","first-page":"100486","DOI":"10.1016\/j.jlr.2023.100486","volume":"65","author":"C Nguyen","year":"2023","unstructured":"Nguyen C, Saint-Pol J, Dib S, Pot C, Gosselet F. 25-Hydroxycholesterol in health and diseases. J Lipid Res. 2023;65:100486.","journal-title":"J Lipid Res"},{"key":"4197_CR38","doi-asserted-by":"publisher","first-page":"e170453","DOI":"10.1172\/JCI170453","volume":"134","author":"NE Boutagy","year":"2024","unstructured":"Boutagy NE, Gamez-Mendez A, Fowler JWM, Zhang H, Chaube BK, Esplugues E, et al. Dynamic metabolism of endothelial triglycerides protects against atherosclerosis in mice. J Clin Invest. 2024;134:e170453.","journal-title":"J Clin Invest"},{"key":"4197_CR39","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.tem.2024.11.004","volume":"36","author":"KM Citrin","year":"2025","unstructured":"Citrin KM, Chaube B, Fern\u00e1ndez-Hernando C, Su\u00e1rez Y. Intracellular endothelial cell metabolism in vascular function and dysfunction. Trends Endocrinol Metab. 2025;36:744\u201355.","journal-title":"Trends Endocrinol Metab"},{"key":"4197_CR40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fcvm.2018.00130","volume":"5","author":"X Zhang","year":"2018","unstructured":"Zhang X, Sessa WC, Fern\u00e1ndez-Hernando C. Endothelial Transcytosis of Lipoproteins in Atherosclerosis. Front Cardiovasc Med. 2018;5:130.","journal-title":"Front Cardiovasc Med"},{"key":"4197_CR41","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1161\/ATVBAHA.124.320940","volume":"44","author":"E Jang","year":"2024","unstructured":"Jang E, Ho TWW, Brumell JH, Lefebvre F, Wang C, Lee WL. IL-1\u03b2 Induces LDL Transcytosis by a Novel Pathway Involving LDLR and Rab27a. Arterioscler Thromb Vasc Biol. 2024;44:2053\u201368.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4197_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.yjmcc.2014.02.012","volume":"72","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Yang X, Bian F, Wu P, Xing S, Xu G, et al. TNF-\u03b1 promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: crosstalk between NF-\u03baB and PPAR-\u03b3. J Mol Cell Cardiol. 2014;72:85\u201394.","journal-title":"J Mol Cell Cardiol"},{"key":"4197_CR43","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1161\/CIRCULATIONAHA.113.002714","volume":"128","author":"H Xiao","year":"2013","unstructured":"Xiao H, Lu M, Lin TY, Chen Z, Chen G, Wang W-C, et al. SREBP2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility. Circulation. 2013;128:632\u201342.","journal-title":"Circulation"},{"key":"4197_CR44","doi-asserted-by":"publisher","first-page":"101156","DOI":"10.1016\/j.jbc.2021.101156","volume":"297","author":"AL Fisher","year":"2021","unstructured":"Fisher AL, Srole DN, Palaskas NJ, Meriwether D, Reddy ST, Ganz T, et al. Iron loading induces cholesterol synthesis and sensitizes endothelial cells to TNF\u03b1-mediated apoptosis. J Biol Chem. 2021;297:101156. https:\/\/doi.org\/10.1016\/j.jbc.2021.101156.","journal-title":"J Biol Chem"},{"key":"4197_CR45","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.79529","volume":"11","author":"JWM Fowler","year":"2022","unstructured":"Fowler JWM, Zhang R, Tao B, Boutagy NE, Sessa WC. Inflammatory stress signaling via NF-kB alters accessible cholesterol to upregulate SREBP2 transcriptional activity in endothelial cells. eLife. 2022;11:e79529.","journal-title":"eLife"},{"key":"4197_CR46","doi-asserted-by":"publisher","first-page":"100411","DOI":"10.1016\/j.jlr.2023.100411","volume":"64","author":"JWM Fowler","year":"2023","unstructured":"Fowler JWM, Boutagy NE, Zhang R, Horikami D, Whalen MB, Romanoski CE, et al. SREBP2 regulates the endothelial response to cytokines via direct transcriptional activation of KLF6. J Lipid Res. 2023;64:100411. https:\/\/doi.org\/10.1016\/j.jlr.2023.100411.","journal-title":"J Lipid Res"},{"key":"4197_CR47","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/cns.12014","volume":"18","author":"X Feng","year":"2012","unstructured":"Feng X, Xiong J, Qin H, Liu W, Chen R, Shang W, et al. Fluoxetine induces hepatic lipid accumulation via both promotion of the SREBP1c-related lipogenesis and reduction of lipolysis in primary mouse hepatocytes. CNS Neurosci Ther. 2012;18:974\u201380.","journal-title":"CNS Neurosci Ther"},{"key":"4197_CR48","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.neulet.2005.10.096","volume":"395","author":"MB Raeder","year":"2006","unstructured":"Raeder MB, Fern\u00f8 J, Glambek M, Stansberg C, Steen VM. Antidepressant drugs activate SREBP and up-regulate cholesterol and fatty acid biosynthesis in human glial cells. Neurosci Lett. 2006;395:185\u201390.","journal-title":"Neurosci Lett"},{"key":"4197_CR49","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1002\/jat.4109","volume":"41","author":"S Lu","year":"2021","unstructured":"Lu S, Ma Z, Gu Y, Li P, Chen Y, Bai M, et al. Downregulation of glucose-6-phosphatase expression contributes to fluoxetine-induced hepatic steatosis. J Appl Toxicol. 2021;41:1232\u201340.","journal-title":"J Appl Toxicol"},{"key":"4197_CR50","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.biocel.2014.07.019","volume":"54","author":"J Xiong","year":"2014","unstructured":"Xiong J, Yang H, Wu L, Shang W, Shan E, Liu W, et al. Fluoxetine suppresses AMP-activated protein kinase signaling pathway to promote hepatic lipid accumulation in primary mouse hepatocytes. Int J Biochem Cell Biol. 2014;54:236\u201344.","journal-title":"Int J Biochem Cell Biol"},{"key":"4197_CR51","doi-asserted-by":"publisher","first-page":"8089","DOI":"10.3390\/ijms22158089","volume":"22","author":"A Tkachev","year":"2021","unstructured":"Tkachev A, Stekolshchikova E, Bobrovskiy DM, Anikanov N, Ogurtsova P, Park DI, et al. Long-term fluoxetine administration causes substantial lipidome alteration of the juvenile macaque brain. Int J Mol Sci. 2021;22:8089.","journal-title":"Int J Mol Sci"},{"key":"4197_CR52","doi-asserted-by":"publisher","first-page":"847322","DOI":"10.3389\/fendo.2022.847322","volume":"13","author":"A Nozari","year":"2022","unstructured":"Nozari A, Gagn\u00e9 R, Lu C, Yauk C, Trudeau VL. Brief developmental exposure to fluoxetine causes life-long alteration of the brain transcriptome in zebrafish. Front Endocrinol. 2022;13:847322.","journal-title":"Front Endocrinol"},{"key":"4197_CR53","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1038\/aps.2017.207","volume":"39","author":"S Pan","year":"2018","unstructured":"Pan S, Tan Y, Yao S, Xin Y, Yang X, Liu J, et al. Fluoxetine induces lipid metabolism abnormalities by acting on the liver in patients and mice with depression. Acta Pharmacol Sin. 2018;39:1463\u201372.","journal-title":"Acta Pharmacol Sin"},{"key":"4197_CR54","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/JCP.0000000000000582","volume":"36","author":"KK Fjukstad","year":"2016","unstructured":"Fjukstad KK, Engum A, Lydersen S, Dieset I, Steen NE, Andreassen OA, et al. Metabolic abnormalities related to treatment with selective serotonin reuptake inhibitors in patients with schizophrenia or bipolar disorder. J Clin Psychopharmacol. 2016;36:615\u201320.","journal-title":"J Clin Psychopharmacol"},{"key":"4197_CR55","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/00004714-200306000-00016","volume":"23","author":"DL Bailey","year":"2003","unstructured":"Bailey DL, Le Mell\u00e9do J-M. Effects of selective serotonin reuptake inhibitors on cholesterol levels in patients with panic disorder. J Clin Psychopharmacol. 2003;23:317.","journal-title":"J Clin Psychopharmacol"},{"key":"4197_CR56","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/01.jcp.0000237941.56107.b7","volume":"26","author":"A Herr\u00e1n","year":"2006","unstructured":"Herr\u00e1n A, Ram\u00edrez ML, Carrera M, Garc\u00eda-Unzueta MT, Sierra-Biddle D, Rodr\u00edguez-Cabo B, et al. Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels. J Clin Psychopharmacol. 2006;26:538.","journal-title":"J Clin Psychopharmacol"},{"key":"4197_CR57","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.4088\/JCP.v67n1219","volume":"67","author":"MB Raeder","year":"2006","unstructured":"Raeder MB, Bjelland I, Emil Vollset S, Steen VM. Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: the Hordaland Health Study. J Clin Psychiatry. 2006;67:1974\u201382.","journal-title":"J Clin Psychiatry"},{"key":"4197_CR58","first-page":"1525","volume":"16","author":"M Kesim","year":"2011","unstructured":"Kesim M, Tiryaki A, Kadioglu M, Muci E, Kalyoncu NI, Yaris E. The effects of sertraline on blood lipids, glucose, insulin and HBA1C levels: A prospective clinical trial on depressive patients. J Res Med Sci Off J Isfahan Univ Med Sci. 2011;16:1525\u201331.","journal-title":"J Res Med Sci Off J Isfahan Univ Med Sci"},{"key":"4197_CR59","doi-asserted-by":"publisher","first-page":"112040","DOI":"10.1016\/j.diabres.2025.112040","volume":"222","author":"D Liu","year":"2025","unstructured":"Liu D, Guo T, Peng Q, Velu P, Prabahar K, Safargar M, et al. The effect of Fluoxetine on lipid profiles in overweight or obese Individuals: A systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. 2025;222:112040.","journal-title":"Diabetes Res Clin Pract"},{"key":"4197_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/2008-2231-21-4","volume":"21","author":"E Shahsavand Ananloo","year":"2013","unstructured":"Shahsavand Ananloo E, Ghaeli P, Kamkar M-Z, Sadeghi M. Comparing the effects of fluoxetine and imipramine on total cholesterol, triglyceride, and weight in patients with major depression. DARU J Pharm Sci. 2013;21:4.","journal-title":"DARU J Pharm Sci"},{"key":"4197_CR61","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/j.1550-8528.1996.tb00268.x","volume":"4","author":"F Pedrinola","year":"1996","unstructured":"Pedrinola F, Sztejnsznajd C, Lima N, Halpern A, Medeiros-Neto G. The addition of dexfenfluramine to fluoxetine in the treatment of obesity: a randomized clinical trial. Obes Res. 1996;4:549\u201354.","journal-title":"Obes Res"},{"key":"4197_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-025-07441-8","volume":"25","author":"G Tong","year":"2025","unstructured":"Tong G, Zhang C, Li H, Gao X, Velu P, Safargar M, et al. The impact of fluoxetine on obesity and diabetes-related biomarkers in overweight and obese individuals: a systematic review and meta-analysis of randomized controlled trials. BMC Psychiatry. 2025;25:977.","journal-title":"BMC Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04197-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04197-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04197-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:02:18Z","timestamp":1782244938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04197-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4197"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04197-x","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MB received honoraria as a consultant and speaker from Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Lilly, Novo Nordisk, Novartis, and Sanofi. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Primary human umbilical vein endothelial cells (HUVECs; C-12200 and C-12203) and human coronary artery endothelial cells (HCAECs; C-12221) were purchased from PromoCell GmbH, Germany. According to the supplier, human tissues used for isolation of primary human cell cultures are obtained only after written informed consent, and are collected in compliance with applicable European and international ethical standards. No additional human material was collected by the authors for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"318"}}